Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

Pals2 Inhibitors

Pals2 inhibitors are a class of chemical compounds that specifically target the Pals2 protein, a member of the membrane-associated guanylate kinase (MAGUK) family. Pals2, or protein associated with Lin-7, is a scaffolding protein that plays a critical role in the organization of cellular junctions and the maintenance of cell polarity. It interacts with other proteins at tight junctions, such as transmembrane proteins and signaling molecules, to regulate the structural integrity of epithelial and endothelial cells. By inhibiting Pals2, these compounds interfere with the formation of protein complexes at cell junctions, potentially altering cell adhesion and polarity, which are essential for maintaining proper tissue architecture and cellular communication.

Pals2 inhibitors can exert their effects through various mechanisms, such as disrupting the interaction between Pals2 and its binding partners or altering its localization to specific membrane domains. These inhibitors are valuable tools for studying the dynamics of cell junction assembly and disassembly, offering insights into how Pals2 contributes to the stability and function of intercellular junctions. Additionally, these inhibitors provide a way to explore the molecular processes underlying the regulation of tight junctions and cell polarity. By modulating Pals2 activity, researchers can better understand how cells maintain their structural organization and how signaling pathways are coordinated at the cellular junctions to control processes like cell proliferation, differentiation, and migration.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

If the PALS2 gene is normally hypermethylated to maintain expression, 5-Azacytidine could induce DNA demethylation, leading to the silencing of PALS2 transcription.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

This compound could increase histone acetylation specifically at the PALS2 gene locus, resulting in a compact chromatin structure that represses PALS2 mRNA synthesis.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid might promote histone acetylation at the PALS2 locus, causing chromatin remodeling that results in decreased PALS2 promoter activity and reduced protein expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid might bind to retinoic acid receptors that downregulate PALS2 transcription through direct interaction with the PALS2 promoter or interference with transcriptional enhancers.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

By inhibiting mTOR signaling pathways that are potentially responsible for PALS2 protein synthesis, Rapamycin could lead to a decrease in PALS2 mRNA translation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 may interfere with JNK-dependent transcription factor phosphorylation that is crucial for PALS2 gene activation, thereby reducing PALS2 transcription levels.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

This inhibitor could disrupt PI3K/AKT pathway signaling, which may be necessary for PALS2 expression, leading to a consequent drop in PALS2 mRNA and protein levels.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 might inhibit MEK, which in turn could block the activation of transcription factors critical for initiating PALS2 gene transcription, ultimately suppressing PALS2 expression.

Wnt-C59

1243243-89-1sc-475634
sc-475634A
sc-475634B
5 mg
10 mg
50 mg
$214.00
$326.00
$1275.00
1
(0)

This compound could inhibit the production of Wnt ligands, potentially eliminating a stimulatory effect on PALS2 gene expression if PALS2 is a Wnt-responsive gene.

DAPT

208255-80-5sc-201315
sc-201315A
sc-201315B
sc-201315C
5 mg
25 mg
100 mg
1 g
$40.00
$120.00
$480.00
$2141.00
47
(3)

DAPT might block Notch receptor cleavage and subsequent release of the intracellular domain that could act as a transcriptional activator for PALS2, leading to decreased PALS2 mRNA levels.